Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07290335 · ClinicalTrials.gov registry record · NA

Optimizing Strategies to Maximize Patient Recruitment Yield

A NA study of Recruitment, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
100,000
Enrollment target
1
Study location

NCT07290335: Recruiting NA study of Recruitment, sponsored by Emory University.

NCT07290335 is a NA study of Recruitment that is actively recruiting participants, run by Emory University. The registered enrollment target is 100,000 participants, above the 577-participant average among 4 other Recruitment trials with a reported enrollment target (17231% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07290335, a NA study of Recruitment, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
100,000 participants
Enrollment target
1
Study location

Study Summary

This platform trial aims to evaluate the effectiveness of different messaging strategies within a MyChart messaging program for research recruitment. MyChart is a patient portal system within the Electronic Medical Record (EMR), and messages can be sent directly to patients about research opportunities.

Primary Outcome

The primary endpoint is the rate at which individuals respond that they are interested in participating in the study to which they are invited. The primary outcome is a binary variable of "interested" response.

Conditions Studied

Interventions

  • BEHAVIORAL Baseline (control) message
  • BEHAVIORAL Positively-valenced message
  • BEHAVIORAL Payment-inclusive message
  • BEHAVIORAL Positively-valenced, payment-inclusive message

Study Locations (1)

Georgia

  • Emory Healthcare System - Atlanta

Trial Details

FieldValue
Enrollment Target 100,000 participants
Start Date 2026-02-19
Est. Completion 2027-04
Phase NA
Emory University

1,208 total trials

What NCT07290335 shows while recruiting

NCT07290335 is an interventional study that assigns participants to a tested intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 577-participant average among 4 other Recruitment trials with a reported enrollment target (17231% higher).

The record links to 1 condition, with Recruitment appearing as the primary indexed condition, and to 4 interventions - of which Baseline (control) message is the first listed.

NCT07290335 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT07290335 about?

NCT07290335 is a clinical study titled "Optimizing Strategies to Maximize Patient Recruitment Yield". This platform trial aims to evaluate the effectiveness of different messaging strategies within a MyChart messaging program for research recruitment. MyChart is a patient portal system within the Electronic Medical Record (EMR), and messages can be sent directly to patients about research opportunit...

What is the current status of trial NCT07290335?

This trial is currently recruiting. It is a NA study. The enrollment target is 100,000 participants. The study started on 2026-02-19. Estimated completion is 2027-04.

What conditions does trial NCT07290335 study?

This clinical trial studies the following conditions: Recruitment.

What interventions are being tested in trial NCT07290335?

The interventions under investigation include: Baseline (control) message (BEHAVIORAL), Positively-valenced message (BEHAVIORAL), Payment-inclusive message (BEHAVIORAL), Positively-valenced, payment-inclusive message (BEHAVIORAL).

Who is sponsoring clinical trial NCT07290335?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07290335 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Recruitment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02620852 · 100,000 participants · NA

    Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

  • NCT03277365 · 100,000 participants · NA

    MyGeneRank: A Digital Platform for Next-Generation Genetic Studies

  • NCT04281823 · 100,000 participants

    DeBakey Cardiovascular Magnetic Resonance Study

  • NCT04869111 · 100,000 participants · NA

    The BrainHealth Project

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07290335, the US trial registry maintained by the National Library of Medicine. NCT07290335 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.